Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
NDA for New Second-Line Indication of CAR T-Cell Therapy Product YIKAIDA (Axicabtagene Ciloleucel Injection) Approved for CDE Review 2022-10-28 01:37
WuXi Biologics Provides Corporate Updates 2022-10-27 22:13
Simcere Receives FDA Clearance of Investigational New Drug Application (IND) for Bi-functional Fusion Protein, SIM0237 2022-10-27 21:25
Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US 2022-10-27 21:22
Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement 2022-10-27 20:00
Tsinghua SIGS Virtual Open Day 2023 | Where your future starts 2022-10-27 16:59
Antengene to Host Research and Development Day on November 15th and 17th, 2022 2022-10-27 11:07
Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01) 2022-10-27 10:07
Samsung Biologics Reports Third Quarter 2022 Financial Results 2022-10-27 07:35
Waterdrop Opens Its First Community outlet in Shenzhen to Explore the "Insurance + Community" Model 2022-10-26 22:00
Lunit Joins World Economic Forum Global Innovators Community 2022-10-26 21:00
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting 2022-10-26 19:25
WuXi AppTec Reports Record Year-to-Date Results in 2022, Third Quarter Revenue over RMB10 Billion 2022-10-26 19:06
Meet the female scientists who develop cellular and gene therapies 2022-10-26 17:07
Yiling Pharmaceutical Exhibiting its Innovative TCM Products during CHEXPO Macau 2022 2022-10-26 16:52
'SWESD 2022,' The Joint World Conference on Social Work, Education and Social Development to be held in Seoul for four days starting 26th Oct. 2022-10-26 14:46
ImmVira announced its signing of Series C+ financing and negotiation with further investors for the round 2022-10-26 14:26
WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China 2022-10-26 12:30
Alwin Capital's New Dual-Currency Fund Closed and Exceeded Fundraising Target 2022-10-25 23:10
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines 2022-10-25 20:00
1 122 123 124 125 126 801